- 日
- 関
WordNet
- lying between two extremes in time or space or state; "going from sitting to standing without intermediate pushes with the hands"; "intermediate stages in a process"; "intermediate stops on the route"; "an intermediate range plane"
- a substance formed during a chemical process before the desired product is obtained
- the amount per unit size (同)denseness
- a conjugated protein having a lipid component; the principal means for transporting lipids in the blood
PrepTutorEJDIC
- (程度・距離・時間などにおいて)中間の,中間にある(起こる)
- 〈U〉『密集』;『密度』,濃さ / 〈U〉〈C〉(物質の)密度,濃度,比重 / 〈U〉《話》頭の鈍さ,愚鈍さ
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/11/01 06:19:14」(JST)
[Wiki en表示]
|
This article relies largely or entirely upon a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. (October 2015) |
Intermediate-density lipoproteins (IDLs) belong to the lipoprotein particle family and are formed from the degradation of very low-density lipoproteins. IDL is one of the five major groups of lipoproteins (chylomicrons, VLDL, IDL, LDL, HDL) that enable fats and cholesterol to move within the water-based solution of the bloodstream. Each native IDL particle consists of protein that encircles various fatty acids, enabling, as a water-soluble particle, these fatty acids to travel in the aqueous blood environment as part of the fat transport system within the body. Their size is, in general, 25 to 35 nm in diameter, and they contain primarily a range of triacylglycerols and cholesterol esters. They are cleared from the plasma into the liver by receptor-mediated endocytosis, or further degraded to form LDL particles.
(Although one might intuitively assume that "intermediate-density" refers to a density between that of high-density and low-density lipoproteins, it in fact refers to a density between that of low-density and very-low-density lipoproteins. Lipoproteins are classified as less dense when the fat to protein ratio is increased.)
In general, IDL, somewhat similar to low-density lipoprotein (LDL), transports a variety of triglyceride fats and cholesterol and, like LDL, can also promote the growth of atheroma.
VLDL is a large, triglyceride-rich lipoprotein secreted by the liver that transports triglyceride to adipose tissue and muscle. The triglycerides in VLDL are removed in capillaries by the enzyme lipoprotein lipase, and the VLDL returns to the circulation as a smaller particle with a new name, intermediate-density lipoprotein (IDL). The IDL particles have lost most of their triglyceride, but they retain cholesteryl esters. Some of the IDL particles are rapidly taken up by the liver; others remain in circulation, where they undergo further triglyceride hydrolysis and are converted to LDL. A distinguishing feature of the IDL particle is their content of multiple copies of the receptor ligand ApoE in addition to a single copy of ApoB-100. The multiple copies of ApoE allow IDL to bind to the LDL receptor with a very high affinity. When IDL is converted to LDL, the ApoE leaves the particle and only the ApoB-100 remains. Thereafter, the affinity for the LDL receptor is much reduced.[1]
References
- Brown MS and Goldstein JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47.
Lipids: lipoprotein particle metabolism
|
|
Lipoprotein particle classes and subclasses |
- delivery of TGs: Chylomicron
- VLDL
- delivery of C and CE: IDL
- LDL
- lb LDL
- sd LDL
- Lp(a)
- HDL
|
|
Apolipoproteins |
- APOA
- APOB
- APOC
- APOD
- APOE
- APOH
- SAA
|
|
Extracellular enzymes |
|
|
Lipid transfer proteins |
|
|
Cell surface receptors |
- IDL: LRP
- LRP1
- LRP1B
- LRP2
- LRP3
- LRP4
- LRP5
- LRP5L
- LRP6
- LRP8
- LRP10
- LRP11
- LRP12
- LDL: LDLR
- LRPAP1
|
|
ATP-binding cassette transporter |
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- phospholipid
- cholesterol and steroid
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Proteomic profiles reveal age-related changes in coelomic fluid of sea urchin species with different life spans.
- Bodnar A.SourceBermuda Institute of Ocean Sciences, St. George's GE 01, Bermuda. Electronic address: andrea.bodnar@bios.edu.
- Experimental gerontology.Exp Gerontol.2013 May;48(5):525-30. doi: 10.1016/j.exger.2013.01.014. Epub 2013 Feb 8.
- Sea urchins have a different life history from humans and traditional model organisms used to study the process of aging. Sea urchins grow indeterminately, reproduce throughout their life span and some species have been shown to exhibit negligible senescence with no increase in mortality rate at adv
- PMID 23453931
- Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease.
- Haybar H, Assareh A, Ghotbi Y, Torabizadeh M, Bozorgmanesh M.SourcePrevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 19395-4763, Iran; mr_bozorgmanesh@endocrine.ac.ir.
- Heart (British Cardiac Society).Heart.2013 May;99(9):640-8. doi: 10.1136/heartjnl-2012-303560. Epub 2013 Mar 6.
- OBJECTIVES: Pentraxins are a superfamily of multifunctional conserved proteins, some of which are components of the humoral arm of innate immunity and behave as functional ancestors of antibodies. They are divided into short (C reactive protein) and long pentraxins (pentraxin 3; PTX3). We investigat
- PMID 23468517
- ABCA1 Mediates Unfolding of Apolipoprotein AI N Terminus on the Cell Surface Before Lipidation and Release of Nascent High-Density Lipoprotein.
- Wang S, Gulshan K, Brubaker G, Hazen SL, Smith JD.SourceDepartment of Cellular and Molecular Medicine, and Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland OH; and Department of Cardiology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, PR China.
- Arteriosclerosis, thrombosis, and vascular biology.Arterioscler Thromb Vasc Biol.2013 Apr 4. [Epub ahead of print]
- OBJECTIVE: To gain insight into the mechanism by which ABCA1 generates nascent high-density lipoprotein.Approach and Results-HEK293 cells were stably transfected with ABCA1 vectors, encoding wild type, and the W590S and C1477R Tangier disease mutation isoforms, along with the K939M ATP-binding domai
- PMID 23559627
Japanese Journal
- Cholesterol Levels of Six Fractionated Serum Lipoproteins and its Relevance to Coronary Heart Disease Risk Scores
- イオン交換高速液体クロマトグラフィー法を用いたホルスタイン種成乳牛におけるコレステロールリポ蛋白質分画の分析
- 化学療法施行中に重症心筋梗塞を発症した後腹膜原発胚細胞腫の1例
Related Links
- intermediate-density lipoprotein (IDL) a lipid-protein complex with a density between those of very-low-density lipoprotein and low-density lipoprotein. The product has a relatively short half-life and is normally in the blood in very low ...
- Looking for online definition of intermediate density lipoprotein (IDL) in the Medical Dictionary? intermediate density lipoprotein (IDL) explanation free. What is intermediate density lipoprotein (IDL)? Meaning of intermediate density ...
Related Pictures
★リンクテーブル★
[★]
- 英
- intermediate-density lipoprotein、IDL lipoprotein、intermediate density lipoprotein
- 同
- 中間型リポ蛋白、中間型リポタンパク、中間密度リポタンパク、中間型リポ蛋白質、中間密度リポ蛋白質、中間型リポタンパク質、中間密度リポタンパク質
[show details]
[★]
- 関
- IDL lipoprotein
[★]
- 関
- halfway、intermediary、intermediary body、intermedius、intersex、interstitial、interzonal、middle、moderate
[★]
[★]
リポ蛋白 lipoprotein
[★]
リポ蛋白 lipoprotein